Central nervous system vasculitis in VEXAS syndrome: A rare involvemen.


Journal

Clinical neurology and neurosurgery
ISSN: 1872-6968
Titre abrégé: Clin Neurol Neurosurg
Pays: Netherlands
ID NLM: 7502039

Informations de publication

Date de publication:
23 May 2024
Historique:
received: 06 03 2024
revised: 21 05 2024
accepted: 22 05 2024
medline: 28 5 2024
pubmed: 28 5 2024
entrez: 27 5 2024
Statut: aheadofprint

Résumé

VEXAS (Vacuoles, E1 Enzyme, X-linked, autoinflammatory, Somatic) syndrome is a recently described severe adult-onset autoinflammatory disorder mediated by X-linked gene UBA1 somatic mutations, responsible of recurrent fever, skin involvement, chondritis, macrocytic anemia and inflammatory syndrome. Neurological manifestations are rarely described, and predominantly involve peripheral nervous system (PNS) impairment. We report the first central nervous system (CNS) vasculitis in VEXAS syndrome, characterized by headache, cognitive dysfunction and focal signs (cerebellar ataxia). Magnetic resonance imaging (MRI) revealed multifocal white-matter lesions corresponding to recent ischemic strokes, combined with cortical hemorrhagic lesions and gadolinium enhancement of the distal wall vessels. Treatment with methylprednisone, ruxolitinib and tocilizumab led to clinical improvement and a decrease of the inflammatory syndrome. The patient died few months after due to infectious complications. CNS vasculitis, occurring as a manifestation of the systemic auto-inflammatory state of VEXAS syndrome, might be a rare but severe complication. We suggest that it be added to the list of inflammatory vasculopathies. More prospective studies are needed to optimize the treatment.

Identifiants

pubmed: 38801808
pii: S0303-8467(24)00238-5
doi: 10.1016/j.clineuro.2024.108351
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

108351

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest Authors do not have any conflict of interest.

Auteurs

V Langlois (V)

Service de médecine interne et maladies infectieuses, Groupe Hospitalier du Havre, France. Electronic address: vincent.langlois@ch-havre.fr.

A Curie (A)

Service de médecine interne et maladies infectieuses, Groupe Hospitalier du Havre, France; Service de médecine interne, Centre Hospitalier Eure Seine, Evreux, France.

A Demas (A)

Service de neurologie, Groupe hospitalier du Havre, France.

P Etancelin (P)

Laboratoire de génétique oncologique, Centre de lutte contre le cancer Henri Becquerel, Rouen, France.

G Sauvètre (G)

Service de médecine interne, CHU de Rouen, France.

A Leclancher (A)

Service de neurologie, Groupe hospitalier du Havre, France.

A Mekinian (A)

Service de médecine interne, Hôpital Saint Antoine, Paris, France.

Classifications MeSH